Generation and function of reactive oxygen species in dendritic cells during antigen presentation.
Although reactive oxygen species (ROS) have long been considered to play pathogenic roles in various disorders, this classic view is now being challenged by the recent discovery of their physiological roles in cellular signaling. To determine the immunological consequence of pharmacological disruption of endogenous redox regulation, we used a selenium-containing antioxidant compound ebselen known to modulate both thioredoxin and glutaredoxin pathways. Ebselen at 5-20 micro M inhibited Con A-induced proliferation and cytokine production by the HDK-1 T cell line as well as the LPS-triggered cytokine production by XS52 dendritic cell (DC) line. Working with the in vitro-reconstituted Ag presentation system composed of bone marrow-derived DC, CD4(+) T cells purified from DO11.10 TCR-transgenic mice and OVA peptide (serving as Ag), we observed that 1) both T cells and DC elevate intracellular oxidation states upon Ag-specific interaction; 2) ebselen significantly inhibits ROS production in both populations; and 3) ebselen at 5-20 micro M inhibits DC-induced proliferation and cytokine production by T cells as well as T cell-induced cytokine production by DC. Thus, Ag-specific, bidirectional DC-T cell communication can be blocked by interfering with the redox regulation pathways. Allergic contact hypersensitivity responses in BALB/c mice to oxazolone, but not irritant contact hypersensitivity responses to croton oil, were suppressed significantly by postchallenge treatment with oral administrations of ebselen (100 mg/kg per day). These results provide both conceptual and technical frameworks for studying ROS-dependent regulation of DC-T cell communication during Ag presentation and for testing the potential utility of antioxidants for the treatment of immunological disease.
Matsue
Hiroyuki
H
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Edelbaum
Dale
D
Shalhevet
David
D
Mizumoto
Norikatsu
N
Yang
Chendong
C
Mummert
Mark E
ME
Oeda
Junichi
J
Masayasu
Hiroyuki
H
Takashima
Akira
A
D000485:Allergens / Q000008:administration & dosage / Q000276:immunology; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D017951:Antigen Presentation / Q000187:drug effects / Q000276:immunology; D001393:Azoles / Q000378:metabolism / Q000494:pharmacology; D002999:Clone Cells; D003208:Concanavalin A / Q000494:pharmacology; D003713:Dendritic Cells / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism*; D003877:Dermatitis, Contact / Q000276:immunology / Q000473:pathology; D018984:Epitopes, T-Lymphocyte / Q000378:metabolism; D005260:Female; D007509:Irritants / Q000008:administration & dosage / Q000276:immunology; D054833:Isoindoles; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008822:Mice, Transgenic; D016566:Organoselenium Compounds / Q000378:metabolism / Q000494:pharmacology; D010081:Oxazolone / Q000008:administration & dosage / Q000276:immunology; D017382:Reactive Oxygen Species / Q000276:immunology / Q000378:metabolism*; D018417:Th1 Cells / Q000276:immunology / Q000378:metabolism
D000485:Allergens; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001393:Azoles; D018984:Epitopes, T-Lymphocyte; D007509:Irritants; D054833:Isoindoles; D008070:Lipopolysaccharides; D016566:Organoselenium Compounds; D017382:Reactive Oxygen Species; D003208:Concanavalin A; D010081:Oxazolone; C042986:ebselen